| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |